Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Glaucocalyxin D, an ent-kauranoid-type diterpenoid extracted from Rabdosia japonica, exhibits cytotoxic properties against a range of human tumor cell lines, making it a valuable compound for cancer research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Glaucocalyxin D, an ent-kauranoid-type diterpenoid extracted from Rabdosia japonica, exhibits cytotoxic properties against a range of human tumor cell lines, making it a valuable compound for cancer research [1]. |
In vitro | Glaucocalyxin D, at concentrations ranging from 0 to 100 μM over a period of 48 hours, exhibits potent cytotoxic effects on human tumor cell lines A549, CCRF-CEM, HCT116, and HL-60. |
Molecular Weight | 374.47 |
Formula | C22H30O5 |
CAS No. | 140671-02-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Glaucocalyxin D 140671-02-9 inhibitor inhibit